Sort
48,018 grants matching “immunotherapy”
Antibodies for BioDefense using Directed Evolution
$886,188Diversa Corporation · U01 · FY2003 · AI
Immunotherapy for Type 1 Diabetes
$885,432Francine R. Kaufman · Children'S Hospital Of Los Angeles · U01 · FY2007 · DK
Strategies for Prevention of Autoimmunity
$885,307Stanford University · U19 · FY2003 · DK
Advancing treatment and understanding of immunotherapy in glioblastoma
$885,236Nicholas A Butowski · University Of California, San Francisco · U19 · FY2021 · CA
Pediatric AIDS Clinical Trials Group
$885,194University Of California San Diego · U01 · FY2003 · AI
American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)
$885,149Terry B Gernsheimer · University Of Washington · U01 · FY2019 · HL
Prevention of Graft-Versus-Host-Disease in the Era of Adoptive Immunotherapy
$885,028Marie Bleakley · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Blood-based Alzheimer's biomarker detection at the point of care
$885,006Hadi Shafiee · Brigham And Women'S Hospital · R56 · FY2024 · AG
Immunotherapeutic Approaches for AIDS
$884,441George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
TULANE/LSU PEDIATRIC AIDS CLINICAL TRIALS UNIT
$884,360Tulane University Of Louisiana · U01 · FY2001 · AI
Prevention of Graft-Versus-Host-Disease in the Era of Adoptive Immunotherapy
$884,291Marie Bleakley · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA
Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma
$884,176Shumei Song · Coriell Institute For Medical Research · R01 · FY2025 · CA
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
$884,114James L Abbruzzese · Duke University · UM1 · FY2016 · CA
UNIVERSITY OF P.R., PEDIATRIC AIDS CLINICAL TRIALS UNIT
$883,471University Of Puerto Rico Med Sciences · U01 · FY2000 · AI
Evaluation of the Immunogenicity and Efficacy of HIV-1 Clade A BG505 SOSIP.664 Env Glycoprotein Trimer Vaccine Administered with TLR Agonist or Alum Adjuvants
$883,231Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI
Novel Hepatitis B Vaccine and Immunotherapy
$883,119Mansun Law · Scripps Research Institute, The · R56 · FY2024 · AI
Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability
$882,648Jana Portnow · Beckman Research Institute/City Of Hope · U19 · FY2024 · CA
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$882,530Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors
$882,098Jeffrey S Miller · University Of Minnesota · R35 · FY2024 · CA
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
$881,405Marilyn L Kwan · Kaiser Foundation Research Institute · U01 · FY2023 · CA
SPORE in Pancreatic Cancer
$881,136Donald J. Buchsbaum · University Of Alabama At Birmingham · P20 · FY2006 · CA
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma
$880,830Nicole Schmitt · National Institute On Deafness And Other Communication Disorders · ZIA · FY2017 · DC
Biology and Therapy of Lymphopenia
$880,808Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
In vivo hematopoietic stem cell engineering for HIV cure
$880,758Hans-Peter Kiem · University Of Southern California · P01 · FY2025 · HL
Targeting PD-1 Pathway for Functional Cure of AIDS
$880,613Rama Rao Amara · Emory University · R01 · FY2025 · AI